IT Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on IT Press Releases.

June 2026

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

July 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

August 2026

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30
31

Press releases published on June 11, 2026

Jun. 11, 2026

Climb Bio Announces Initial Phase 1b Data Demonstrating On-Target Clinical Activity for Budoprutug in Immune Thrombocytopenia at EHA Congress 2026

GlobeNewswire

Jun. 11, 2026

GURU Organic Energy Delivers 31.6% Revenue Growth and Continued Margin Expansion in Second Quarter 2026

GlobeNewswire

Jun. 11, 2026

GURU Organic Energy affiche une croissance des revenus de 31,6 % et une expansion continue de la marge brute au deuxième trimestre de 2026

GlobeNewswire

$Nurix Therapeutics to Report Updated Phase 1a/b Results for BTK Degrader Bexobrutideg, Highlighting Durable Responses in Relapsed/Refractory CLL/SLL and Promising Activity in Earlier Lines of Therapy$

Jun. 11, 2026

Nurix Therapeutics to Report Updated Phase 1a/b Results for BTK Degrader Bexobrutideg, Highlighting Durable Responses in Relapsed/Refractory CLL/SLL and Promising Activity in Earlier Lines of Therapy

GlobeNewswire

Jun. 11, 2026

Medicenna Strengthens U.S. Patent Estate with Newly Issued and Allowed Patents Across its IL-2, IL-4 and IL-13 Superkine Platforms

GlobeNewswire

$Syndax Announces Publication of SAVE Data on Revuforj® (revumenib) in Combination with Decitabine/Cedazuridine and Venetoclax in Relapsed/Refractory NPM1m, KMT2Ar, and NUP98r AML in the Journal of Clinical Oncology$

Jun. 11, 2026

Syndax Announces Publication of SAVE Data on Revuforj® (revumenib) in Combination with Decitabine/Cedazuridine and Venetoclax in Relapsed/Refractory NPM1m, KMT2Ar, and NUP98r AML in the Journal of Clinical Oncology

GlobeNewswire

Jun. 11, 2026

Quetzal Therapeutics Announces First Patient Dosed in Phase 3 QUATRO-APL Trial of QTX-2101 for Frontline Acute Promyelocytic Leukemia

GlobeNewswire

Pharvaris Announces Annual General Meeting of Shareholders

Jun. 11, 2026

AGIBOT X2 wird zum überraschendsten VIP in Cannes und bringt humanoide Robotik in die Welt der Mode, des Films und des luxuriösen Lifestyles

GlobeNewswire

Jun. 11, 2026

Personnalité la plus inattendue de Cannes, AGIBOT X2 fait entrer la robotique humanoïde dans les domaines de la mode, du cinéma et du luxe

GlobeNewswire

Jun. 11, 2026

Nomagic’s Shoebox Picker Wins Piece Picking Robotics Innovation of the Year

GlobeNewswire

Jun. 11, 2026

Darktrace Finds More Than 80% of Professional Sports Organizations Impacted by Cyber Incidents in the last 12 Months as AI Raises the Cybersecurity Stakes

GlobeNewswire

Jun. 11, 2026

K-Tech Solutions Company Limited and Aurora AZ Energy Ltd. Announce Construction and Testing Progress on Initial 5 MW Capacity Phase of Joint Venture

GlobeNewswire

Jun. 11, 2026

Vietnam-aligned OceanLotus pivots to spy on domestic targets as it takes a more selective approach abroad, ESET Research finds

GlobeNewswire

Aviator Game India 2026: 1Win Launched Aviator Game Bonus Offers In India

Jun. 11, 2026

IT Press Releases: Press Releases

June 2026

July 2026

August 2026

Press releases published on June 11, 2026

Climb Bio Announces Initial Phase 1b Data Demonstrating On-Target Clinical Activity for Budoprutug in Immune Thrombocytopenia at EHA Congress 2026

GURU Organic Energy Delivers 31.6% Revenue Growth and Continued Margin Expansion in Second Quarter 2026

GURU Organic Energy affiche une croissance des revenus de 31,6 % et une expansion continue de la marge brute au deuxième trimestre de 2026

Nurix Therapeutics to Report Updated Phase 1a/b Results for BTK Degrader Bexobrutideg, Highlighting Durable Responses in Relapsed/Refractory CLL/SLL and Promising Activity in Earlier Lines of Therapy

Medicenna Strengthens U.S. Patent Estate with Newly Issued and Allowed Patents Across its IL-2, IL-4 and IL-13 Superkine Platforms

Syndax Announces Publication of SAVE Data on Revuforj® (revumenib) in Combination with Decitabine/Cedazuridine and Venetoclax in Relapsed/Refractory NPM1m, KMT2Ar, and NUP98r AML in the Journal of Clinical Oncology

Quetzal Therapeutics Announces First Patient Dosed in Phase 3 QUATRO-APL Trial of QTX-2101 for Frontline Acute Promyelocytic Leukemia

Pharvaris Announces Annual General Meeting of Shareholders

MSX Launches X Card, Bridging Digital Assets and Global Consumer Payments

BOSS Zhipin's Ongoing Share Repurchases Reach Over RMB1.76 Billion in 2026

AGIBOT X2 wird zum überraschendsten VIP in Cannes und bringt humanoide Robotik in die Welt der Mode, des Films und des luxuriösen Lifestyles

Personnalité la plus inattendue de Cannes, AGIBOT X2 fait entrer la robotique humanoïde dans les domaines de la mode, du cinéma et du luxe

Nomagic’s Shoebox Picker Wins Piece Picking Robotics Innovation of the Year

Darktrace Finds More Than 80% of Professional Sports Organizations Impacted by Cyber Incidents in the last 12 Months as AI Raises the Cybersecurity Stakes

K-Tech Solutions Company Limited and Aurora AZ Energy Ltd. Announce Construction and Testing Progress on Initial 5 MW Capacity Phase of Joint Venture

Vietnam-aligned OceanLotus pivots to spy on domestic targets as it takes a more selective approach abroad, ESET Research finds

Aviator Game India 2026: 1Win Launched Aviator Game Bonus Offers In India

Oculis to Present Privosegtor at Upcoming Clinical Trials at the Summit 2026

Snom launches D895M for high-quality professional IP communication

El nuevo Snom D895M: comunicación IP profesional al más alto nivel

Advanced Search Options